These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 17069538)
1. Targeting the CYP2B 1/cyclophosphamide suicide system to fibroblast growth factor receptors results in a potent antitumoral response in pancreatic cancer models. Huch M; Abate-Daga D; Roig JM; González JR; Fabregat J; Sosnowski B; Mazo A; Fillat C Hum Gene Ther; 2006 Dec; 17(12):1187-200. PubMed ID: 17069538 [TBL] [Abstract][Full Text] [Related]
2. Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors. Kleeff J; Fukahi K; Lopez ME; Friess H; Büchler MW; Sosnowski BA; Korc M Cancer Gene Ther; 2002 Jun; 9(6):522-32. PubMed ID: 12032663 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral activation of cyclophosphamide by retroviral transfer of the cytochrome P450 2B1 in a pancreatic tumor model. Combination with the HSVtk/GCV system. Carrió M; Visa J; Cascante A; Estivill X; Fillat C J Gene Med; 2002; 4(2):141-9. PubMed ID: 11933215 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice. Gu DL; Gonzalez AM; Printz MA; Doukas J; Ying W; D'Andrea M; Hoganson DK; Curiel DT; Douglas JT; Sosnowski BA; Baird A; Aukerman SL; Pierce GF Cancer Res; 1999 Jun; 59(11):2608-14. PubMed ID: 10363982 [TBL] [Abstract][Full Text] [Related]
5. Treatment based on a combination of the CYP2B1/cyclophosphamide system and p53 delivery enhances tumour regression in human pancreatic cancer. Mercadé E; Cascalló M; Carrió M; Calbó J; Gómez-Treviño A; Fillat C; Gómez-Foix AM; Mazo A Ann Oncol; 2001 Mar; 12(3):379-88. PubMed ID: 11332152 [TBL] [Abstract][Full Text] [Related]
6. Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy. Wang W; Zhu NL; Chua J; Swenson S; Costa FK; Schmitmeier S; Sosnowski BA; Shichinohe T; Kasahara N; Chen TC J Neurosurg; 2005 Dec; 103(6):1058-66. PubMed ID: 16381193 [TBL] [Abstract][Full Text] [Related]
7. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene. Chen L; Waxman DJ; Chen D; Kufe DW Cancer Res; 1996 Mar; 56(6):1331-40. PubMed ID: 8640822 [TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors. Printz MA; Gonzalez AM; Cunningham M; Gu DL; Ong M; Pierce GF; Aukerman SL Hum Gene Ther; 2000 Jan; 11(1):191-204. PubMed ID: 10646650 [TBL] [Abstract][Full Text] [Related]
9. Gene transfer mediated by native versus fibroblast growth factor-retargeted adenoviral vectors into lung cancer cells. Qin M; Escuadro B; Sharma S; Batra RK Am J Respir Cell Mol Biol; 2005 Mar; 32(3):211-7. PubMed ID: 15626775 [TBL] [Abstract][Full Text] [Related]
13. Head and neck squamous cell carcinoma targeted chemosensitization. Figures MR; Wobb J; Araki K; Liu T; Xu L; Zhu H; O'Malley BW; Li D Otolaryngol Head Neck Surg; 2009 Aug; 141(2):177-83. PubMed ID: 19643248 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and antiangiogenesis by fibroblast growth factor 2-targeted Ad-TK cancer gene therapy. Saito K; Khan K; Sosnowski B; Li D; O'Malley BW Laryngoscope; 2009 Apr; 119(4):665-74. PubMed ID: 19213040 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of cyclophosphamide sensitivity in squamous cell carcinoma transfected with cytochrome P-450 2B1. Iida M; Kojima H; Miyazaki H; Manome Y Am J Otolaryngol; 2005; 26(1):22-7. PubMed ID: 15635577 [TBL] [Abstract][Full Text] [Related]
16. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand. Hoganson DK; Sosnowski BA; Pierce GF; Doukas J Mol Ther; 2001 Jan; 3(1):105-12. PubMed ID: 11162317 [TBL] [Abstract][Full Text] [Related]
17. Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer. Ding Y; Wen Y; Spohn B; Wang L; Xia W; Kwong KY; Shao R; Li Z; Hortobagyi GN; Hung MC; Yan DH Clin Cancer Res; 2002 Oct; 8(10):3290-7. PubMed ID: 12374701 [TBL] [Abstract][Full Text] [Related]
18. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model. Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378 [TBL] [Abstract][Full Text] [Related]
19. Intratumoral injection of encapsulated cells producing an oxazaphosphorine activating cytochrome P450 for targeted chemotherapy. Karle P; Müller P; Renz R; Jesnowski R; Saller R; von Rombs K; Nizze H; Liebe S; Günzburg WH; Salmons B; Löhr M Adv Exp Med Biol; 1998; 451():97-106. PubMed ID: 10026857 [TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models. Vernejoul F; Faure P; Benali N; Calise D; Tiraby G; Pradayrol L; Susini C; Buscail L Cancer Res; 2002 Nov; 62(21):6124-31. PubMed ID: 12414637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]